Know Cancer

or
forgot password

Epidemiological Registry Describing Treatment Reality and Therapy Modalities of Patients With Lung Cancer (NSCLC, SCLC and Neuroendocrine Tumors) Requiring Therapy.


N/A
18 Years
N/A
Open (Enrolling)
Both
Observational Study, Registry

Thank you

Trial Information

Epidemiological Registry Describing Treatment Reality and Therapy Modalities of Patients With Lung Cancer (NSCLC, SCLC and Neuroendocrine Tumors) Requiring Therapy.


Inclusion Criteria:



- all patients suffering from Small Cell Lung Cancer (SCLC), Non Small Lung Cancer
(NSCLC) or neuroendocrine tumors receiving therapy

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Documentation of actually used therapy forms in bronchial carcinoma requiring treatment

Outcome Time Frame:

3 years per patient

Safety Issue:

No

Principal Investigator

Hans-Werner Tessen, MD

Investigator Role:

Principal Investigator

Authority:

Germany: Ethics Commission

Study ID:

IOM TLK

NCT ID:

NCT01192919

Start Date:

January 2010

Completion Date:

September 2016

Related Keywords:

  • Observational Study
  • Registry
  • bronchial carcinoma
  • progression free survival
  • registry
  • therapy-reality
  • observation
  • therapy sequences
  • NSCLC
  • SCLC
  • Germany
  • Erlotinib
  • Bevacizumab
  • Pemetrexed
  • Lung Neoplasms
  • Neuroendocrine Tumors

Name

Location